Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance.

Cao, Yaquan; Wu, Chunli; Ma, Liying

Cao, Yaquan; Wu, Chunli; Ma, Liying.

Afiliación

Cao Y; College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
Wu C; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Ma L; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Science and Institute of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan, China.

J Biochem Mol Toxicol ; 38(1): e23587, 2024 Jan.

Article en En | MEDLINE | ID: mdl-38014925

Asunto(s)

Lisina; Neoplasias; Humanos; Resistencia a Antineoplásicos; Neoplasias/tratamiento farmacológico; Proteínas Nucleares; Proteínas Represoras; Histona Demetilasas con Dominio de Jumonji

Palabras clave

KDM5B; chemoresistance; combination therapy; tumor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Lisina / Neoplasias Límite: Humans Idioma: En Revista: J Biochem Mol Toxicol Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA / TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google